tiprankstipranks
Veraxa Biotech (VRXA)
NASDAQ:VRXA
US Market
VRXA
Veraxa Biotech
RESEARCH TOOLSreports

Veraxa Biotech (VRXA) Income Statement

13 Followers

Veraxa Biotech Income Statement

Last quarter (Q1 2026), Veraxa Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Veraxa Biotech's net income was $180.50K. See Veraxa Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 1.79M$ 702.96K
Depreciation and Amortization
$ 0.00$ 0.00
EBITDA
$ -1.79M$ -702.96K
Operating Income
$ -1.79M$ -702.96K
Other Income/Expenses
$ 10.77M$ 4.84M
Pretax Income
$ 8.99M$ 4.14M
Net Income
$ 8.99M$ 4.14M
Per Share Metrics
Basic EPS
$ 0.36$ 0.15
Diluted EPS
$ 0.36$ 0.15
Weighted Average Shares Outstanding
 25.30M 26.73M
Weighted Average Shares Outstanding (Diluted)
 25.30M 26.73M
Currency in USD

Veraxa Biotech Earnings and Revenue History